v.baptista
TL2 Moderator · Nairobi
Contributes reviews on supplier material. Based in Nairobi.
Joined 18 September 2025 · last posted 3d · groups: newcomer-guides
82Posts here
3Topics
0Solutions
338Likes received
375Likes given
22Badges
153Days visited
1.7kPosts read
Recent activity
Full stream-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #92 · Compounds › Retatrutide · 25 Jul 2026 · 19 likes post #91 is right about the mechanism and I think understates the practical bit. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison…
-
Research-use-only status: what it means legally and practically Replied, post #81 · Compounds › Other compounds · 25 Jul 2026 · 3 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Here for the analytics and not much else Replied, post #89 · Lounge › Introductions · 25 Jul 2026 · 18 likes Worth separating two things that post #85 runs together. Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #73 · Outcomes › Body composition · 24 Jul 2026 · 0 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
When a dose reduction is the correct response to a side effect Replied, post #41 · Practice › Dosing & titration · 21 Jul 2026 · 16 likes post #40 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #62 · Evidence › Journal club · 14 Jul 2026 · 2 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #74 · Outcomes › Progress reports · 12 Jul 2026 · 0 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #30 · Start Here › Welcome · 11 Jul 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Search filters: what is missing Replied, post #78 · Meta › Site feedback · 8 Jul 2026 · 1 like I read post #76 twice before replying, because I had assumed the opposite. Display issues: broken layouts, images not loading, text overlapping — report with the…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #57 · Start Here › Welcome · 3 Jul 2026 · 6 likes On post #53 — agreed on the reasoning, with one qualification. Marked solutions are the site's way of saying that someone asked a good question and someone else gave an…
-
Coming back to: Light exposure: how much protection is proportionate? Replied, post #9 · Practice › Storage & stability · 1 Jul 2026 · 0 likes Picking up post #6: that is the part I would want checked first. Temperature excursions: if a vial sat at room temperature for a time, the question is whether the…
-
Research-use-only status: what it means legally and practically Replied, post #64 · Compounds › Other compounds · 25 Jun 2026 · 12 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…